Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in ZYME — Zymeworks Inc.

CIK 80255 BALTIMORE, MD
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,006,024
+$117,430 QoQ
Shares Held
38,486
+8.5% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 202 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. ZYME ranks #176 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in ZYME

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,006,024 38,486
2026-03-31 $888,594 35,487
2025-12-31 $757,882 28,784
2025-09-30 $458,017 26,816
2025-06-30 $336,540 26,816
2025-03-31 $287,185 24,113
2024-12-31 $315,975 21,583
2024-09-30 $230,267 18,348
2024-06-30 $145,257 17,069
2024-03-31 $164,785 15,664
2023-12-31 $138,322 13,313
2023-09-30 $73,296 11,561
2023-06-30 $93,502 10,822